Skip to content

STERIS STE Other Commercial Liabilities

Other Commercial Liabilities at other companies

Baxter International logo
Baxter InternationalBAX
Mesa Laboratories logo
Mesa LaboratoriesMLAB
Boston Scientific logo
Boston ScientificBSX
IAR
Integra LifeSciencesIART
Fortive logo
FortiveFTV
Sotera Health logo
Sotera HealthSHC

Other financials

Income statement

See full
Revenue$1.6B+7.3%
Gross profit$697.2M+8.8%
Operating income$316.8M+46.6%
Net income$220.2M+51.2%
EPS (diluted)$2.24+52.4%

Balance sheet

See full
Cash & equivalents$439.6M+156%
Total debt$2.1B-10.3%
Total equity$7.2B+8.8%
Total assets$10.7B+5.8%

Cash flow

See full
Operating cash flow$335.4M+28.6%
CapEx$90.2M+27.2%
Free cash flow$245.2M+29.1%

Valuation

See full
Market cap$20.86B-6.4%
Enterprise value$22.51B-6.0%
P/E26.7×-7.8×
P/S3.5×-0.5×

Profitability

See full
Gross margin44.2%+0.2pp
Operating margin18.6%+2.7pp
Net margin13.2%+1.9pp
FCF margin16.4%+2.1pp

Returns & leverage

See full
Return on equity11.3%+1.8pp
Debt / equity0.3×-0.1×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is STERIS's other commercial liabilities?
STERIS (STE) reported other commercial liabilities of $401.9M in Q1 2026.
How has STERIS's other commercial liabilities changed year-over-year?
STERIS's other commercial liabilities increased by 9.2% year-over-year, from $368.1M to $401.9M.
What is the long-term trend for STERIS's other commercial liabilities?
Over 5 years (2021 to 2026), STERIS's other commercial liabilities has grown at a 12.8% compound annual growth rate (CAGR), from $220.56M to $401.9M.